RB family members as predictive and prognostic factors in human cancer

被引:0
|
作者
G Scambia
S Lovergine
V Masciullo
机构
[1] Catholic University,Division of Gynecologic Oncology
[2] Sbarro Institute for Cancer Research,undefined
[3] College of Science and Technology,undefined
[4] Temple University,undefined
来源
Oncogene | 2006年 / 25卷
关键词
pRb; pRb2; p130; prognostic factor; predictive factor;
D O I
暂无
中图分类号
学科分类号
摘要
The retinoblastoma family members – pRb, pRb2/p130 and p107 – are tumor suppressor genes involved in controlling four major cellular processes: growth arrest, apoptosis, differentiation and angiogenesis. Molecular genetic studies have identified abnormalities of these tumor suppressor genes in a large proportion of human cancers. These genetic alterations have emerged as significant factors in the pathogenesis and progression of many types of tumors and are therefore likely to provide relevant information to assess risk in cancer patients. There is a pressing clinical need to identify prognostic and predictive factors for patients with cancer, because there is an undeniable importance in being able to determine which patients will have a favorable outcome without further therapy (prognostic factor) and which will need some additional treatment (predictive factor). This review examines the predictive and/or prognostic role of each retinoblastoma family member in human cancer.
引用
收藏
页码:5302 / 5308
页数:6
相关论文
共 50 条
  • [31] Roles of the pathologist in neoadjuvant chemotherapy: evaluation of response, prognostic and predictive factors
    Penault-Llorca, F
    Vincent-Salomon, A
    ANNALES DE PATHOLOGIE, 2003, 23 (06) : 555 - 563
  • [32] HER2 as a prognostic and predictive marker for breast cancer
    Cooke, T
    Reeves, J
    Lanigan, A
    Stanton, P
    ANNALS OF ONCOLOGY, 2001, 12 : 23 - 28
  • [33] The correlation of c-erbB-2 oncoprotein and established prognostic factors in human breast cancer
    Sütterlin, MW
    Haller, A
    Gassel, AM
    Peters, K
    Caffier, H
    Dietl, J
    ANTICANCER RESEARCH, 2000, 20 (6D) : 5083 - 5088
  • [34] Survival and prognostic factors of early ovarian cancer
    Villa, A
    Parazzini, F
    Acerboni, S
    Guarnerio, P
    Bolis, G
    BRITISH JOURNAL OF CANCER, 1998, 77 (01) : 123 - 124
  • [35] Prognostic factors in stage IB gastric cancer
    Aoyama, Toru
    Yoshikawa, Takaki
    Fujikawa, Hirohito
    Hayashi, Tsutomu
    Ogata, Takashi
    Cho, Haruhiko
    Yamada, Takanobu
    Hasegawa, Shinichi
    Tsuchida, Kazuhito
    Yukawa, Norio
    Oshima, Takashi
    Oba, Mari S.
    Morita, Satoshi
    Rino, Yasushi
    Masuda, Munetaka
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (21) : 6580 - 6585
  • [36] Prognostic factors in primary breast cancer patients
    Gohring, UJ
    Scharl, A
    MEDIZINISCHE WELT, 1998, 49 (08): : 359 - 366
  • [37] PROGNOSTIC FACTORS IN ADVANCED BREAST-CANCER
    KOLBL, O
    KIRICUTA, IC
    WILLNER, J
    BOHNDORF, W
    TUMORDIAGNOSTIK & THERAPIE, 1994, 15 (01) : 1 - 5
  • [38] Detection of prognostic factors in metastatic breast cancer
    Tazhibi, Mehdi
    Fayaz, Mahsa
    Mokarian, Fariborz
    JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2013, 18 (04): : 283 - 290
  • [39] Bone Metastasis Prognostic Factors in Breast Cancer
    Yazdani, Akram
    Dorri, Sara
    Atashi, Alireza
    Shirafkan, Hoda
    Zabolinezhad, Hedieh
    BREAST CANCER-BASIC AND CLINICAL RESEARCH, 2019, 13
  • [40] Prognostic factors in stage IB gastric cancer
    Toru Aoyama
    Takaki Yoshikawa
    Hirohito Fujikawa
    Tsutomu Hayashi
    Takashi Ogata
    Haruhiko Cho
    Takanobu Yamada
    Shinichi Hasegawa
    Kazuhito Tsuchida
    Norio Yukawa
    Takashi Oshima
    Mari S Oba
    Satoshi Morita
    Yasushi Rino
    Munetaka Masuda
    World Journal of Gastroenterology, 2014, (21) : 6580 - 6585